MedTrace Logo

Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial

NCT00522262 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2015-01-15

No results posted yet for this study

Summary

The purpose of the ALPHA Trial is to examine the physiologic changes that occur in a woman's body when she begins exercising that may be related to a change in her risk of getting breast cancer.

Conditions

  • Breast Neoplasms

Interventions

BEHAVIORAL

Aerobic exercise intervention

Women in the exercise arm underwent a year-long exercise intervention of five days per week of 45 minutes/session of moderate-vigorous intensity aerobic exercise.

Sponsors & Collaborators

  • Canadian Breast Cancer Research Alliance

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • University of Calgary

    collaborator OTHER

  • AHS Cancer Control Alberta

    lead OTHER

Principal Investigators

  • Christine M Friedenreich, PhD · Alberta Health services

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2006-06-30
Completion
2007-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00522262 on ClinicalTrials.gov